NCT05694845View on ClinicalTrials.gov

Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2026

Conditions
Cholangiocarcinoma
Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT05694845 - Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma | Biotech Hunter | Biotech Hunter